Binzhou Zhiyuan Biotechnology opens a new chapter

Shandong Binzhou Zhiyuan Biotechnology Co.,Ltd has been actively exploring the infinite applications of cyclodextrins in human life since the inception in 2010. Now Zhiyuan has developed into a hi-tech enterprise focusing on the R&D, production and application of cyclodextrin derivatives and inclusion compounds, with total assets exceeding CNY100 million and an annual overall production capacity of 5000 metric tons.

So far, Zhiyuan’s product system has more than 50 varieties in five categories among which, pharmaceutical excipients including hydroxypropyl beta cyclodextrins and sulfobutyl ether-beta-cyclodextrin sodium have obtained pharmaceutical approval numbers and clinical permission, and received CDE registration in China and DMF in the US.

Cyclodextrin reagent products are exclusively provided for university laboratories and research institutions at home and abroad. Moreover, Zhiyuan can provide cyclodextrin inclusion compound customization services for customers.

Zhiyuan has introduced advanced production equipment from home and abroad, built a GMP clean production workshop for pharmaceutical excipients and a large medicine warehouse, which are designed with scientific, environment-friendly and highly clean materials, and can realize automatic, digital and intelligent operation.

Focusing on customers, zhiyuan creates customer experience in all aspects, and provides all-round support for customers before, during and after sales. Having independent intellectual property rights, selling well all over the world with stable supply capacity and high-quality services.

Now Zhiyuan is actively practicing in the core idea of “making continuous progress to win your acceptance and recommendation”.  Our aim is to propel the development of cyclodextrin technology worldwide.